<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neuroimaging</journal-id>
<journal-title>Frontiers in Neuroimaging</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neuroimaging</abbrev-journal-title>
<issn pub-type="epub">2813-1193</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnimg.2024.1356713</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroimaging</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>3D inversion recovery ultrashort echo time MRI can detect demyelination in cuprizone-treated mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Searleman</surname> <given-names>Adam C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2565857/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Ma</surname> <given-names>Yajun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1048317/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sampath</surname> <given-names>Srihari</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sampath</surname> <given-names>Srinath</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Bussell</surname> <given-names>Robert</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Chang</surname> <given-names>Eric Y.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1530856/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Deaton</surname> <given-names>Lisa</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Schumacher</surname> <given-names>Andrew M.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Du</surname> <given-names>Jiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/944002/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Radiology, University of California, San Diego</institution>, <addr-line>San Diego, CA</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Radiology Service, Veterans Affairs San Diego Healthcare System</institution>, <addr-line>San Diego, CA</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Novartis Institutes for BioMedical Research</institution>, <addr-line>San Diego, CA</addr-line>, <country>United States</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Bioengineering, University of California, San Diego</institution>, <addr-line>San Diego, CA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Xi-Nian Zuo, Beijing Normal University, China</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Nian Wang, Indiana University Bloomington, United States</p>
<p>Tsen-Hsuan Lin, GlaxoSmithKline, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Jiang Du <email>jiangdu&#x00040;ucsd.edu</email></corresp>
<fn fn-type="present-address" id="fn002"><p>&#x02020;Present address: Robert Bussell, CorTechs AI, San Diego, CA, United States</p></fn>
<fn fn-type="equal" id="fn003"><p>&#x02021;These authors have contributed equally to this work</p></fn></author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>3</volume>
<elocation-id>1356713</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 Searleman, Ma, Sampath, Sampath, Bussell, Chang, Deaton, Schumacher and Du.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Searleman, Ma, Sampath, Sampath, Bussell, Chang, Deaton, Schumacher and Du</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Purpose</title>
<p>To test the ability of inversion-recovery ultrashort echo time (IR-UTE) MRI to directly detect demyelination in mice using a standard cuprizone mouse model.</p></sec>
<sec>
<title>Methods</title>
<p>Non-aqueous myelin protons have ultrashort T<sub>2</sub>s and are &#x0201C;invisible&#x0201D; with conventional MRI sequences but can be detected with UTE sequences. The IR-UTE sequence uses an adiabatic inversion-recovery preparation to suppress the long T<sub>2</sub> water signal so that the remaining signal is from the ultrashort T<sub>2</sub> myelin component. In this study, eight 8-week-old C57BL/6 mice were fed cuprizone (<italic>n</italic> = 4) or control chow (<italic>n</italic> = 4) for 5 weeks and then imaged by 3D IR-UTE MRI. The differences in IR-UTE signal were compared in the major white matter tracts in the brain and correlated with the Luxol Fast Blue histochemical marker of myelin.</p></sec>
<sec>
<title>Results</title>
<p>IR-UTE signal decreased in cuprizone-treated mice in white matter known to be sensitive to demyelination in this model, such as the corpus callosum, but not in white matter known to be resistant to demyelination, such as the internal capsule. These findings correlated with histochemical staining of myelin content.</p></sec>
<sec>
<title>Conclusions</title>
<p>3D IR-UTE MRI was sensitive to cuprizone-induced demyelination in the mouse brain, and is a promising noninvasive method for measuring brain myelin content.</p></sec></abstract>
<kwd-group>
<kwd>MRI</kwd>
<kwd>IR-UTE</kwd>
<kwd>myelin imaging</kwd>
<kwd>mouse model</kwd>
<kwd>cuprizone</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="9"/>
<word-count count="6003"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Brain Imaging Methods</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>1 Introduction</title>
<p>In the central nervous system, myelin is a component of oligodendrocytes defined by its ultrastructure of multiple lamellae of protein-rich lipid bilayers; myelin insulates the axons of certain nerves to facilitate saltatory conduction and provides trophic support (Morell and Quarles, <xref ref-type="bibr" rid="B24">1999a</xref>). The extent of myelination modulates the function and health of axons and is dynamically regulated throughout the lifespan and in response to a variety of neurologic conditions (Young et al., <xref ref-type="bibr" rid="B43">2013</xref>; Duncan and Radcliff, <xref ref-type="bibr" rid="B8">2016</xref>).</p>
<p>The development of robust and specific biomarkers of myelination would facilitate further advancements in the diagnosis, monitoring, and treatment of demyelinating diseases. For instance, there has been recent interest in the development of promoters of remyelination as complementary to the current immunosuppressive treatment of multiple sclerosis (Magalon et al., <xref ref-type="bibr" rid="B21">2012</xref>; Deshmukh et al., <xref ref-type="bibr" rid="B5">2013</xref>; Plemel et al., <xref ref-type="bibr" rid="B26">2017</xref>; Lubetzki et al., <xref ref-type="bibr" rid="B16">2020</xref>), an autoimmune demyelinating disease that most commonly affects young adults and ultimately results in progressive functional impairment, cognitive deficits, and early mortality (Lucchinetti et al., <xref ref-type="bibr" rid="B17">2005</xref>; Popescu et al., <xref ref-type="bibr" rid="B27">2013</xref>). An imaging-based biomarker of myelin would be crucial for the development of these potential remyelinating agents at both the pre-clinical and clinical stages.</p>
<p>Myelin imaging is challenging because the T<sub>2</sub> of myelin protons (T<sub>2</sub> from several &#x003BC;s to a few 100&#x00027;s of &#x003BC;s) is much shorter than the minimal echo times (TEs; no less than several ms) of conventional sequences (Horch et al., <xref ref-type="bibr" rid="B13">2011</xref>; Wilhelm et al., <xref ref-type="bibr" rid="B39">2012</xref>; Du et al., <xref ref-type="bibr" rid="B6">2014a</xref>; Sheth et al., <xref ref-type="bibr" rid="B29">2016</xref>). In addition, the longer T<sub>2</sub> water protons comprise over 90% of the MRI signal in the brain (Fan et al., <xref ref-type="bibr" rid="B10">2018</xref>). We have previously shown that adiabatic inversion recovery prepared ultrashort echo time (IR-UTE) sequences with nominal TEs as short as 8 &#x003BC;s are able to robustly suppress long-T<sub>2</sub> water signals and generate a high contrast myelin image on a clinical 3T scanner (Du et al., <xref ref-type="bibr" rid="B6">2014a</xref>,<xref ref-type="bibr" rid="B7">b</xref>). This short T<sub>2</sub> signal persists after removing most of the myelin-associated water fraction by D<sub>2</sub>O exchange (Fan et al., <xref ref-type="bibr" rid="B9">2017</xref>, <xref ref-type="bibr" rid="B10">2018</xref>; Seifert et al., <xref ref-type="bibr" rid="B28">2017</xref>), suggesting that the IR-UTE sequence is detecting signal from semisolid myelin protons. Myelin is comprised of &#x0007E;40&#x02013;45% lipids/cholesterol, 10&#x02013;15% protein, and 40% water (Morell and Quarles, <xref ref-type="bibr" rid="B25">1999b</xref>). The majority of the myelin protons detected by UTE sequences are thought to originate from the long-chain methylenes of the bilayers, with additional contributions from cholesterol, choline, and proteins (Horch et al., <xref ref-type="bibr" rid="B13">2011</xref>; Wilhelm et al., <xref ref-type="bibr" rid="B39">2012</xref>). The IR-UTE sequence has also been shown to detect demyelinated MS lesions as confirmed by autopsy (Sheth et al., <xref ref-type="bibr" rid="B29">2016</xref>, <xref ref-type="bibr" rid="B30">2017</xref>).</p>
<p>This study was designed to test the capability of the IR-UTE sequence in detection of demyelination using an animal model. In adult C57BL/6 mice, the copper chelator cuprizone induces demyelination with well-characterized temporal and regional dynamics, notably resulting in pronounced demyelination of the caudal corpus callosum (CC) after 5&#x02013;6 weeks of exposure (Hiremath et al., <xref ref-type="bibr" rid="B12">1998</xref>; Mason et al., <xref ref-type="bibr" rid="B22">2001</xref>; Matsushima and Morell, <xref ref-type="bibr" rid="B23">2001</xref>; Taylor et al., <xref ref-type="bibr" rid="B34">2010</xref>). Additional acute changes are likely reactive to demyelination including mild edema, microgliosis, astrocytosis, and axonal injury; however there is minimal inflammation compared to models such as experimental autoimmune encephalitis (Matsushima and Morell, <xref ref-type="bibr" rid="B23">2001</xref>; Gudi et al., <xref ref-type="bibr" rid="B11">2009</xref>). Thus, the C57BL/6 cuprizone model is well-suited for determining the sensitivity of IR-UTE for acute demyelination.</p>
<p>In this study, eight 8-week-old C57BL/6 mice were fed cuprizone (<italic>n</italic> = 4) or control chow (<italic>n</italic> = 4) for 5 weeks and then imaged by 3D IR-UTE MRI and compared with conventional diffusion tensor imaging (DTI). The differences in IR-UTE signal were compared in the major white matter tracts in the brain and correlated with the Luxol Fast Blue (LFB) histochemical marker of myelin.</p></sec>
<sec sec-type="materials and methods" id="s2">
<title>2 Materials and methods</title>
<sec>
<title>2.1 Sample preparation</title>
<p>All animal studies conformed to institutional IACUC-approved protocols. Ten 8-week-old female C57BL/6 mice were included in this study. Five mice were given 0.2% cuprizone chow (Sigma Aldrich, St Louis, MO; Harlan Laboratories, Inc., Madison, Wisconsin) <italic>ad lib</italic> for 5 weeks, and five controls were given chow lacking cuprizone for 5 weeks prior to being sacrificed for imaging and analysis. This cuprizone dose and duration were chosen to induce maximal regional demyelination in the caudal corpus callosum in this mouse strain (Horch et al., <xref ref-type="bibr" rid="B13">2011</xref>; Wilhelm et al., <xref ref-type="bibr" rid="B39">2012</xref>; Du et al., <xref ref-type="bibr" rid="B6">2014a</xref>; Sheth et al., <xref ref-type="bibr" rid="B29">2016</xref>). One mouse from each group was used for image optimization and excluded from further analysis due to extended imaging times, which may have altered the biological characteristics of the myelin and surrounding tissues. The mice were decapitated and their heads skinned and then flash frozen in liquid nitrogen until analysis to prevent temporal effects related to scan order. Each head was warmed in a room temperature water bath for 2 h immediately prior to MRI to allow for a consistent brain temperature between specimens given the effect of temperature on T<sub>1</sub> and thus nulling time.</p></sec>
<sec>
<title>2.2 MRI</title>
<p>Brain imaging was performed on a Bruker 7T BioSpec (Billerica, MA) scanner using a mouse brain surface coil for signal reception. The specimens were placed in 15 mL conical tubes on a cardboard insert to facilitate consistent positioning in the center of the coil. No solution was added to the tubes. A conventional T<sub>2</sub>-weighted fast spin echo (T<sub>2</sub>-FSE) sequence, with repetition time (TR) = 2,760 ms, TE = 40 ms, and echo train length (ETL) = 8, was used for anatomic imaging. A conventional two-dimensional adiabatic inversion recovery prepared FSE (2D IR-FSE) sequence, with TR = 8,000 ms, TE = 18.6 ms, and inversion times (TIs) = 60, 150, 300, 450, 600, 750, 900, 1,200, 1,500, and 2,000 ms, was used to measure T<sub>1</sub> of the long T<sub>2</sub> white matter components using a single coronal image of the ventral hippocampal commissure. A 3D IR-UTE sequence was used to image myelin, using the following parameters: TR = 1,000 ms, TI = 382.5 ms, TE = 20 &#x003BC;s, FOV = 2.0 &#x000D7; 2.0 &#x000D7; 2.0 cm<sup>3</sup>, matrix = 110 &#x000D7; 110 &#x000D7; 110, flip angle = 15&#x000B0;, number of excitations (NEX) = 4. To speed up data acquisition, 25 spokes centered on TI were acquired per IR preparation, with 5 ms from the start of one spoke to the next, leading to a total scan time of 100 min. The same 3D IR-UTE sequence was repeated with TE = 2.0 ms and NEX = 1. Similar imaging parameters were used for the T<sub>2</sub>-FSE and IR-FSE sequences. Echo planar imaging based DTI MRI was performed using 30 non-colinear gradient directions with gradient b-values = 0, 750, 1,500, and 2,000 s/mm<sup>2</sup>, TR = 4,000 ms, TE = 23 ms, and ETL = 13, for a total scan time of 25 min.</p></sec>
<sec>
<title>2.3 Histology</title>
<p>Immediately after imaging, mouse brains were removed intact, fixed in zinc formalin, and then embedded in paraffin using standard protocols as previously described (Beckmann et al., <xref ref-type="bibr" rid="B3">2018</xref>). One of the control mouse brains was damaged during sample processing and excluded from further histological analysis. Five micron sections were stained with LFB using standard protocols as previously described (Beckmann et al., <xref ref-type="bibr" rid="B3">2018</xref>). Myelin content was semi-quantitatively measured in the genu of the corpus callosum based on staining density as follows: the corpus callosum in each section was visually identified and outlined as the region of interest (ROI) for analysis using the NDP View software for NanoZoomer scanners (Hamamatsu, Photonics, Shizuoka, Japan). The myelin density was then calculated as the LFB optical density within this ROI. LFB densities from nine corpus callosum sections per animal were averaged, and this was compared across 3&#x02013;4 animals per group.</p></sec>
<sec>
<title>2.4 Region of interest selection</title>
<p>The 3D IR-UTE images of a control mouse were mapped to anatomical structures using the Allen Mouse Brain Atlas as a reference (Allen Institute for Brain Science, <xref ref-type="bibr" rid="B1">2004</xref>). Regions of interest (ROIs) were generated in two ways. First, ROIs were drawn manually for the genu and splenium of the CC, ventral hippocampal commissure (VHC), and internal capsule by an investigator blinded to group assignment using standardized criteria for ROI selection to ensure consistency. Secondly, ROIs were generated in a semi-automated fashion from a common IR-UTE template. To remove the influence of signal from the calvarium and other extracranial structures on the registration method, brain extraction was performed using custom Matlab scripts (The Mathworks Inc., Natick, MA). The IR-UTE template was generated using Advanced Normalization Tools (Avants et al., <xref ref-type="bibr" rid="B2">2008</xref>) using symmetric diffeomorphic image registration with a cross-correlation metric from IR-UTE images of an untreated mouse. Each specimen was individually registered to this common template. The ROI analysis was done by manually drawing the ROI on the template and using the inverse transformation to map to the corresponding ROI in the original image space. Both ROI analyses were comparable; however, the backpropagation of the ROIs was not as reliable and therefore the first analysis is presented as it was considered to be more accurate. The template-registered IR-UTE images were also analyzed by averaging the registered IR-UTE images in the control mice and the cuprizone-treated mice to obtain averaged IR-UTE signal for each voxel. Subtraction of the averaged control IR-UTE map from the averaged cuprizone-treated IR-UTE map will demonstrate differences in signal for each voxel between these two groups, which was then analyzed for regional patterns of change.</p></sec>
<sec>
<title>2.5 Data analysis</title>
<p>The IR-UTE absolute signal was obtained from magnitude images. A coil sensitivity map was generated using the magnitude images from the same IR-UTE sequence on a degassed phantom of 20% H<sub>2</sub>O and 80% D<sub>2</sub>O with 35.5 mM MnCl<sub>2</sub> (for <inline-formula><mml:math id="M1"><mml:msubsup><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>*</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> of 355 ms) in a 15 mL conical tube. The map was then smoothened with a Gaussian filter with size = 4 and &#x003C3; = 2 and scaled to a maximum value of 1. The IR-UTE signal from each specimen was normalized to this coil sensitivity map by simple division. The fractional anisotropy (FA), axial diffusivity (AD), and radial diffusivity (RD) were generated using the <italic>dtifit</italic> function in FDT (Jbabdi et al., <xref ref-type="bibr" rid="B14">2012</xref>), and compared to the IR-UTE signal using the Pearson correlation coefficient. T<sub>1</sub> values of white matter were calculated using custom code in Matlab in the ventral hippocampal commissure using the normalized maximum likelihood estimate (assuming a Rician distribution) and non-linear least squares fitting. Statistical analysis was performed using the R statistical programming language (v3.4.1) using the Wilcoxon rank-sum test for each ROI. A <italic>p</italic>-value of &#x0003C; 0.05 was considered statistically significant.</p></sec></sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<p>Representative images of the optimized IR-UTE sequence of a control mouse brain are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. The IR-UTE image in <xref ref-type="fig" rid="F1">Figures 1B</xref>, <xref ref-type="fig" rid="F1">C</xref> demonstrates high signal intensity in the major white matter tracts, including the corpus callosum, internal capsule, dorsal and ventral hippocampal commissures, and deep cerebellar white matter; intermediate signal in mixed white and gray matter structures such as the basal ganglia and both superior and inferior colliculi; and minimal signal from cortical gray matter and cerebral spinal fluid (CSF). The high signal in the calvarium seen only on IR-UTE and not FSE images reflects ultrashort T<sub>2</sub> signal from cortical bone, and there is additional signal from retrobulbar fat. The later echo time of TE = 2 ms in <xref ref-type="fig" rid="F1">Figure 1D</xref> has dramatically reduced signal intensities, notably with the majority of the white matter tracts now demonstrating less signal than residual CSF, indicating that the majority of the white matter IR-UTE signal has ultrashort T<sub>2</sub>. The retrobulbar fat, bone marrow fat, and minimal CSF signal are more apparent in the TE = 2 ms image due to longer T<sub>2</sub>s.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Representative coronal images of an untreated adult C57BL/6 mouse. <bold>(A)</bold> T2 weighted FSE, <bold>(B, C)</bold> IR-UTE at TE = 0.020 ms with and without annotations, <bold>(D)</bold> IR-UTE at TE = 2 ms [displayed with a 10X narrower window than <bold>(B)</bold> to show detail]. BSC, Brachium of the superior colliculus; DHC and VHC, dorsal and ventral hippocampal commissure, respectively.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnimg-03-1356713-g0001.tif"/>
</fig>
<p>The IR-UTE signal visually decreased in the cuprizone-treated mice in several white matter tracts that are known to be sensitive to cuprizone-induced demyelination (<xref ref-type="fig" rid="F2">Figure 2</xref>). Axial images through the ventral hippocampal commissure and splenium of the corpus callosum demonstrate the greatest decrease in signal intensity in the corpus callosum and to a lesser extent in the ventral hippocampal commissure and white matter of the basal ganglia. In contrast, there was no significant signal change in the internal capsule, which is known to be resistant to cuprizone (Yang et al., <xref ref-type="bibr" rid="B42">2009</xref>). These findings are confirmed to be statistically significant with quantitative analysis using ROIs (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Averaged IR-UTE signal from untreated and cuprizone treated mice. IR-UTE images were registered to a common template after brain extraction and then averaged. These averaged axial images are displayed at the level of the <bold>(A)</bold> ventral hippocampal commissure and <bold>(B)</bold> splenium corpus callosum. On the right, subtraction images are shown such that areas of decreased signal in the cuprizone-treated mice are red, and areas of no change are white. Note that the largest decrease in signal was in the splenium of the corpus callosum <bold>(B)</bold>, and the lack of signal differences in the internal capsule <bold>(A)</bold> and midbrain structures <bold>(B)</bold> that are resistant to cuprizone.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnimg-03-1356713-g0002.tif"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>(A)</bold> Example of ROI placement in a representative control mouse on coronal IR-UTE images at TE = 0.02 ms. In the top right figure, the red ROI corresponds to the genu corpus callosum and the blue ROI corresponds to the ventral hippocampal commissure. <bold>(B)</bold> Average magnitude of IR-UTE images at TE = 0.02 ms for selected ROIs. Bars represent 95% confidence intervals. (a.u.), arbitrary units.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnimg-03-1356713-g0003.tif"/>
</fig><p>DTI imaging also was able to detect a difference between the control and cuprizone-treated mice. Demyelination is thought to be associated with a decrease in total fractional anisotropy, specifically with an increase in radial diffusivity as the loss of myelin bilayers allows water molecules to diffuse in a radial direction from the axon tracts (Xie et al., <xref ref-type="bibr" rid="B41">2010</xref>). In contrast, axial diffusivity is more sensitive to axonal damage, which transiently changes during early treatment with cuprizone (Sun et al., <xref ref-type="bibr" rid="B33">2006</xref>). As expected and in line with prior studies of DTI imaging of cuprizone-treated mice, a decrease in fractional anisotropy and an increase in radial diffusivity were seen in the splenium of the corpus callosum, whereas there was no statistically significant change in axial diffusivity. The IR-UTE signal correlated with both fractional anisotropy and radial diffusivity, but only had a weak correlation with axial diffusivity that was not statistically significant (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>IR-UTE signal correlates with <bold>(A)</bold> fractional anisotropy and <bold>(B)</bold> radial diffusivity, but not <bold>(C)</bold> axial diffusivity in cuprizone-treated mice. Both fractional anisotropy and radial diffusivity but not axial diffusivity were different between cuprizone-treated and untreated mice with <italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnimg-03-1356713-g0004.tif"/>
</fig>
<p>Both the IR-UTE and DTI imaging results are corroborated by semi-quantitative histochemical analysis of myelin using LFB staining (<xref ref-type="fig" rid="F5">Figure 5</xref>). All of the cuprizone-treated mice had decreased myelin staining in the genu of the corpus callosum compared to the control mice; however complete demyelination was not achieved in this study. Additionally, T<sub>1</sub> mapping demonstrates that cuprizone treatment did not significantly change the T<sub>1</sub> of the ventral hippocampal commissure (<xref ref-type="fig" rid="F6">Figure 6</xref>). Therefore, the TI<sub>null</sub> of the long <inline-formula><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>*</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> components does not significantly change in this model. Otherwise, it could have resulted in artifactual signal intensity changes.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Decreased Luxol Fast Blue (LFB) staining in cuprizone treated mice compared with control mice. The plane of sectioning is analogous to <xref ref-type="fig" rid="F2">Figure 2A</xref>, showing decreased myelin in both the genu of the corpus callosum and the ventral hippocampal commissure.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnimg-03-1356713-g0005.tif"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>The T1 of myelin in the ventral hippocampal commissure is unchanged by cuprizone treatment.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnimg-03-1356713-g0006.tif"/>
</fig>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>This study demonstrated that the 3D IR-UTE sequence is able to detect demyelination with decreased myelin signal in an animal model of acute demyelination. The ability of the IR-UTE sequence to detect the ultrashort T<sub>2</sub> signal and suppress the long T<sub>2</sub> signal was demonstrated in mouse brains, similar to prior work using <italic>in vitro</italic> phantoms and human volunteers (Du et al., <xref ref-type="bibr" rid="B6">2014a</xref>; Sheth et al., <xref ref-type="bibr" rid="B30">2017</xref>; Fan et al., <xref ref-type="bibr" rid="B10">2018</xref>). The mice treated with cuprizone demonstrated loss of IR-UTE signal in white matter tracts known to be sensitive to cuprizone but no changes in white matter tracts that are known to be resistant, whereas the IR-UTE signal in white matter tracts of control mice was unchanged. The IR-UTE signal was also correlated with findings using DTI MRI. The 3D IR-UTE measurement of demyelination was further confirmed by LFB staining. These findings demonstrate that the IR-UTE signal was sensitive to myelin loss in the cuprizone mouse model.</p>
<p>Many of the existing methods for myelin imaging and quantification detect myelin indirectly through its interactions with myelin-associated water, and have been shown to detect demyelination in the cuprizone model and other animal models. These include magnetic transference (MT)-based imaging methods (Zaaraoui et al., <xref ref-type="bibr" rid="B44">2008</xref>; Varma et al., <xref ref-type="bibr" rid="B36">2015</xref>; Khodanovich et al., <xref ref-type="bibr" rid="B15">2017</xref>), T<sub>2</sub> relaxometry/myelin water fraction imaging (Thiessen et al., <xref ref-type="bibr" rid="B35">2013</xref>; Wood et al., <xref ref-type="bibr" rid="B40">2016</xref>), diffusion based imaging methods (Song et al., <xref ref-type="bibr" rid="B31">2005</xref>; Sun et al., <xref ref-type="bibr" rid="B33">2006</xref>; Wang et al., <xref ref-type="bibr" rid="B38">2011</xref>), quantitative susceptibility mapping (Wang et al., <xref ref-type="bibr" rid="B37">2019</xref>), and others. However, these methods may also be sensitive to other pathologic changes including microgliosis, edema, and mild axonal injury that accompany demyelination in this model (Wood et al., <xref ref-type="bibr" rid="B40">2016</xref>). Directly imaging myelin protons using IR-UTE would be expected to improve specificity for myelin loss in the setting of heterogeneous pathological changes, or may complement these other methods. The indirect measures of myelin are sensitive to B<sub>1</sub> and B<sub>0</sub> inhomogeneities and may be complicated by edema and iron deposition. Unlike IR-UTE, conventional MRI techniques also cannot measure myelin relaxation times (e.g., T1 and T2<sup>&#x0002A;</sup> relaxation times), which may allow for a direct assessment of myelin quality.</p>
<p>Recently, another UTE-based method was found to correlate with histological markers of myelin in the cuprizone model better than the myelin water fraction and RD and similar to the MT-based macromolecular fraction (Soustelle et al., <xref ref-type="bibr" rid="B32">2019</xref>). This Diff-UTE sequence uses diffusion gradients for suppression of long T<sub>2</sub> water signals, which allows relative preservation of the ultrashort T<sub>2</sub> signal at a short TR. In contrast, the IR-UTE sequence uses IR preparation for long T<sub>2</sub> signal suppression, allowing for recovery of the ultrashort T<sub>2</sub> signal using a longer TR and multispoke acquisition per IR preparation (Carl et al., <xref ref-type="bibr" rid="B4">2016</xref>; Ma et al., <xref ref-type="bibr" rid="B19">2020b</xref>). The IR-UTE sequence is more robust to B<sub>1</sub> inhomogeneity and does not require assumptions about the T<sub>1</sub> and T<sub>2</sub> of myelin for gradient tuning, which is required in Diff-UTE imaging of myelin for appropriate signal nulling of diffusive long-T2 components of the white matter (Soustelle et al., <xref ref-type="bibr" rid="B32">2019</xref>); however, inversion time needs to be carefully determined for IR-UTE imaging. We have recently designed a Double-Echo Sliding Inversion Recovery Ultrashort Echo Time (DESIRE-UTE) method which allows image reconstruction at a wide range of inversion times so that the optimal inversion time does not need to be chosen prospectively (Ma et al., <xref ref-type="bibr" rid="B20">2020c</xref>). Another approach is a short-TR adiabatic inversion-recovery UTE (STAIR-UTE) method which allows robust long T<sub>2</sub> signal suppression with optimized short TR/TI pairs (Ma et al., <xref ref-type="bibr" rid="B18">2020a</xref>). In addition, the Diff-UTE study was performed on mouse brains that had been fixed, which may alter the MR properties of myelin. The specificity of the IR-UTE and Diff-UTE sequences have not yet been tested during remyelination or in other models of demyelination.</p>
<p>There are several limitations of this study. First, the sample size of both the treated and control mice was small, owing to the fact that this study was designed as a proof-of-concept for future studies. Additionally, complete demyelination was not achieved, which limited the ability to examine other contributors to the ultrashort T<sub>2</sub> IR-UTE signal such as inflammation and gliosis. A possible reason for myelin not being as low as expected could be animals not eating enough, or variable amounts, of the cuprizone-containing diet. Future studies will be needed to test the specificity of the IR-UTE signal for myelin in the setting of both demyelination and remyelination using other models of demyelination, and to investigate the advantages and disadvantages over conventional MRI techniques for myelin quantification.</p></sec>
<sec sec-type="conclusions" id="s5">
<title>5 Conclusion</title>
<p>In conclusion, the 3D IR-UTE method was able to robustly detect the ultrashort T<sub>2</sub> components in major white matter tracts of the mouse brain with decreased IR-UTE signal of myelin during cuprizone-induced demyelination as confirmed by LFB staining. Therefore, 3D IR-UTE is a promising non-invasive method for measuring brain myelin content in mouse models of demyelination.</p></sec>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The animal study was approved by IACUC at UCSD and at Novartis Institutes for BioMedical Research. The study was conducted in accordance with the local legislation and institutional requirements.</p></sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>ACS: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing&#x02014;original draft, Writing&#x02014;review &#x00026; editing. YM: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing&#x02014;original draft, Writing&#x02014;review &#x00026; editing. SrihS: Resources, Supervision, Writing&#x02014;review &#x00026; editing. SrinS: Resources, Supervision, Writing&#x02014;review &#x00026; editing. RB: Data curation, Methodology, Resources, Software, Writing&#x02014;review &#x00026; editing. EC: Conceptualization, Funding acquisition, Methodology, Resources, Supervision, Writing&#x02014;review &#x00026; editing. LD: Investigation, Methodology, Resources, Writing&#x02014;review &#x00026; editing. AMS: Investigation, Methodology, Resources, Writing&#x02014;review &#x00026; editing. JD: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing&#x02014;original draft, Writing&#x02014;review &#x00026; editing.</p></sec>
</body>
<back>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The authors acknowledge grant support from the National Institutes of Health (1R01 NS092650, RF1AG075717, R01AR075825, R01AR079484, R21AR075851, and T32EB005970), VA Research and Development Services (Merit Awards I01CX001388, 1I01BX005952, and I01CX002211), and GE Healthcare. The animal model and histology was provided by Novartis Institutes for BioMedical Research, which did not contribute to the analysis and interpretation of the results of this study. Novartis was not involved in the decision to publish this manuscript or its preparation, but did review the manuscript prior to submission with no requested alterations.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>LD and AMS were employed by Novartis. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr"><p>CC, Corpus callosum; DTI, Diffusion tensor imaging; ETL, Echo train length; FA, Fractional anisotropy; FSE, Fast spin echo; IR-UTE, Inversion-recovery ultrashort echo time (IR-UTE); LFB, Luxol Fast Blue; MT, Magnetic transference; NEX, Number of excitations; RD, Radial diffusivity; ROI, region of interest; TE, echo time; TI, Inversion time; TR, Repetition time; VHC, ventral hippocampal commissure.</p></fn></fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="book"><person-group person-group-type="author"><collab>Allen Institute for Brain Science</collab></person-group> (<year>2004</year>). <source>Allen Mouse Brain Atlas [Dataset]</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>Allen Institute for Brain Science</publisher-name>.</citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avants</surname> <given-names>B. B.</given-names></name> <name><surname>Epstein</surname> <given-names>C. L.</given-names></name> <name><surname>Grossman</surname> <given-names>M.</given-names></name> <name><surname>Gee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain</article-title>. <source>Med. Image Anal</source>. <volume>12</volume>, <fpage>26</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.media.2007.06.004</pub-id><pub-id pub-id-type="pmid">17659998</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beckmann</surname> <given-names>N.</given-names></name> <name><surname>Giorgetti</surname> <given-names>E.</given-names></name> <name><surname>Neuhaus</surname> <given-names>A.</given-names></name> <name><surname>Zurbruegg</surname> <given-names>S.</given-names></name> <name><surname>Accart</surname> <given-names>N.</given-names></name> <name><surname>Smith</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945</article-title>. <source>Acta Neuropathol. Commun</source>. <volume>6</volume>:<fpage>9</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-018-0510-8</pub-id><pub-id pub-id-type="pmid">29448957</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carl</surname> <given-names>M.</given-names></name> <name><surname>Bydder</surname> <given-names>G. M.</given-names></name> <name><surname>Du</surname> <given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>UTE imaging with simultaneous water and fat signal suppression using a time-efficient multispoke inversion recovery pulse sequence</article-title>. <source>Magn. Reson. Med</source>. <volume>76</volume>, <fpage>577</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.25823</pub-id><pub-id pub-id-type="pmid">26309221</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deshmukh</surname> <given-names>V. A.</given-names></name> <name><surname>Tardif</surname> <given-names>V.</given-names></name> <name><surname>Lyssiotis</surname> <given-names>C. A.</given-names></name> <name><surname>Green</surname> <given-names>C. C.</given-names></name> <name><surname>Kerman</surname> <given-names>B.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>A regenerative approach to the treatment of multiple sclerosis</article-title>. <source>Nature</source> <volume>502</volume>, <fpage>327</fpage>&#x02013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1038/nature12647</pub-id><pub-id pub-id-type="pmid">24107995</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>J.</given-names></name> <name><surname>Ma</surname> <given-names>G.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Carl</surname> <given-names>M.</given-names></name> <name><surname>Szeverenyi</surname> <given-names>N. M.</given-names></name> <name><surname>VandenBerg</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014a</year>). <article-title>Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner</article-title>. <source>NeuroImage</source> <volume>87</volume>(Suppl.C), <fpage>32</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.10.053</pub-id><pub-id pub-id-type="pmid">24188809</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>J.</given-names></name> <name><surname>Sheth</surname> <given-names>V.</given-names></name> <name><surname>He</surname> <given-names>Q.</given-names></name> <name><surname>Carl</surname> <given-names>M.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Corey-Bloom</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2014b</year>). <article-title>Measurement of T1 of the ultrashort T2<sup>&#x0002A;</sup> components in white matter of the brain at 3T</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e103296</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103296</pub-id><pub-id pub-id-type="pmid">25093859</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname> <given-names>I. D.</given-names></name> <name><surname>Radcliff</surname> <given-names>A. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Inherited and acquired disorders of myelin: the underlying myelin pathology</article-title>. <source>Exp. Neurol</source>. <volume>283</volume>, <fpage>452</fpage>&#x02013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.04.002</pub-id><pub-id pub-id-type="pmid">27068622</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>S. J.</given-names></name> <name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Chang</surname> <given-names>E. Y.</given-names></name> <name><surname>Bydder</surname> <given-names>G. M.</given-names></name> <name><surname>Du</surname> <given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Inversion recovery ultrashort echo time imaging of ultrashort T2 tissue components in ovine brain at 3 T: a sequential D<sub>2</sub>O exchange study</article-title>. <source>NMR Biomed</source>. <volume>30</volume>:<fpage>3767</fpage>. <pub-id pub-id-type="doi">10.1002/nbm.3767</pub-id><pub-id pub-id-type="pmid">28731616</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>S-J.</given-names></name> <name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Searleman</surname> <given-names>A.</given-names></name> <name><surname>Szeverenyi</surname> <given-names>N. M.</given-names></name> <name><surname>Bydder</surname> <given-names>G. M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Yet more evidence that myelin protons can be directly imaged with UTE sequences on a clinical 3T scanner: bicomponent T2<sup>&#x0002A;</sup> analysis of native and deuterated ovine brain specimens</article-title>. <source>Magn. Reson. Med</source>. <volume>80</volume>, <fpage>538</fpage>&#x02013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.27052</pub-id><pub-id pub-id-type="pmid">29271083</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gudi</surname> <given-names>V.</given-names></name> <name><surname>Moharregh-Khiabani</surname> <given-names>D.</given-names></name> <name><surname>Skripuletz</surname> <given-names>T.</given-names></name> <name><surname>Koutsoudaki</surname> <given-names>P. N.</given-names></name> <name><surname>Kotsiari</surname> <given-names>A.</given-names></name> <name><surname>Skuljec</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Regional differences between grey and white matter in cuprizone induced demyelination</article-title>. <source>Brain Res</source>. <volume>1283</volume>(Suppl.C), <fpage>127</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.06.005</pub-id><pub-id pub-id-type="pmid">19524552</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiremath</surname> <given-names>M. M.</given-names></name> <name><surname>Saito</surname> <given-names>Y.</given-names></name> <name><surname>Knapp</surname> <given-names>G. W.</given-names></name> <name><surname>Ting</surname> <given-names>J. P. Y.</given-names></name> <name><surname>Suzuki</surname> <given-names>K.</given-names></name> <name><surname>Matsushima</surname> <given-names>G. K.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice</article-title>. <source>J. Neuroimmunol</source>. <volume>92</volume>, <fpage>38</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-5728(98)00168-4</pub-id><pub-id pub-id-type="pmid">9916878</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horch</surname> <given-names>R. A.</given-names></name> <name><surname>Gore</surname> <given-names>J. C.</given-names></name> <name><surname>Does</surname> <given-names>M. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Origins of the ultrashort-T21H NMR signals in myelinated nerve: a direct measure of myelin content?</article-title> <source>Magn. Reson. Med</source>. <volume>66</volume>, <fpage>24</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.22980</pub-id><pub-id pub-id-type="pmid">21574183</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jbabdi</surname> <given-names>S.</given-names></name> <name><surname>Sotiropoulos</surname> <given-names>S. N.</given-names></name> <name><surname>Savio</surname> <given-names>A. M.</given-names></name> <name><surname>Gra&#x000F1;a</surname> <given-names>M.</given-names></name> <name><surname>Behrens</surname> <given-names>T. E. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Model-based analysis of multishell diffusion MR data for tractography: how to get over fitting problems</article-title>. <source>Magn. Reson. Med</source>. <volume>68</volume>, <fpage>1846</fpage>&#x02013;<lpage>1855</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.24204</pub-id><pub-id pub-id-type="pmid">22334356</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khodanovich</surname> <given-names>M. Y.</given-names></name> <name><surname>Sorokina</surname> <given-names>I. V.</given-names></name> <name><surname>Glazacheva</surname> <given-names>V. Y.</given-names></name> <name><surname>Akulov</surname> <given-names>A. E.</given-names></name> <name><surname>Nemirovich-Danchenko</surname> <given-names>N. M.</given-names></name> <name><surname>Romashchenko</surname> <given-names>A. V.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model</article-title>. <source>Sci. Rep</source>. <volume>7</volume>:<fpage>46686</fpage>. <pub-id pub-id-type="doi">10.1038/srep46686</pub-id><pub-id pub-id-type="pmid">28436460</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lubetzki</surname> <given-names>C.</given-names></name> <name><surname>Zalc</surname> <given-names>B.</given-names></name> <name><surname>Williams</surname> <given-names>A.</given-names></name> <name><surname>Stadelmann</surname> <given-names>C.</given-names></name> <name><surname>Stankoff</surname> <given-names>B.</given-names></name></person-group> (<year>2020</year>). <article-title>Remyelination in multiple sclerosis: from basic science to clinical translation</article-title>. <source>Lancet Neurol</source>. <volume>19</volume>, <fpage>678</fpage>&#x02013;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(20)30140-X</pub-id><pub-id pub-id-type="pmid">32702337</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lucchinetti</surname> <given-names>C. F.</given-names></name> <name><surname>Parisi</surname> <given-names>J.</given-names></name> <name><surname>Bruck</surname> <given-names>W.</given-names></name></person-group> (<year>2005</year>). <article-title>The pathology of multiple sclerosis</article-title>. <source>Neurol. Clin</source>. <volume>23</volume>, <fpage>77</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.ncl.2004.09.002</pub-id><pub-id pub-id-type="pmid">15661089</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>Y. J.</given-names></name> <name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Wei</surname> <given-names>Z.</given-names></name> <name><surname>Cai</surname> <given-names>Z.</given-names></name> <name><surname>Xue</surname> <given-names>Y.</given-names></name> <name><surname>Lee</surname> <given-names>R. R.</given-names></name> <etal/></person-group>. (<year>2020a</year>). <article-title>Myelin imaging in human brain using a short repetition time adiabatic inversion recovery prepared ultrashort echo time (STAIR-UTE) MRI sequence in multiple sclerosis</article-title>. <source>Radiology</source> <volume>297</volume>, <fpage>392</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1148/radiol.2020200425</pub-id><pub-id pub-id-type="pmid">32779970</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>Y. J.</given-names></name> <name><surname>Searleman</surname> <given-names>A. C.</given-names></name> <name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Fan</surname> <given-names>S. J.</given-names></name> <name><surname>Wong</surname> <given-names>J.</given-names></name> <name><surname>Xue</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2020b</year>). <article-title>Volumetric imaging of myelin <italic>in vivo</italic> using 3D inversion recovery-prepared ultrashort echo time cones magnetic resonance imaging</article-title>. <source>NMR Biomed</source>. <volume>33</volume>:<fpage>e4326</fpage>. <pub-id pub-id-type="doi">10.1002/nbm.4326</pub-id><pub-id pub-id-type="pmid">32691472</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>Y. J.</given-names></name> <name><surname>Searleman</surname> <given-names>A. C.</given-names></name> <name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Wong</surname> <given-names>J.</given-names></name> <name><surname>Chang</surname> <given-names>E. Y.</given-names></name> <name><surname>Corey-Bloom</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2020c</year>). <article-title>Whole-brain myelin imaging using 3D double-echo sliding inversion recovery ultrashort echo time (DESIRE UTE) MRI</article-title>. <source>Radiology</source> <volume>294</volume>, <fpage>362</fpage>&#x02013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1148/radiol.2019190911</pub-id><pub-id pub-id-type="pmid">31746689</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magalon</surname> <given-names>K.</given-names></name> <name><surname>Zimmer</surname> <given-names>C.</given-names></name> <name><surname>Cayre</surname> <given-names>M.</given-names></name> <name><surname>Khaldi</surname> <given-names>J.</given-names></name> <name><surname>Bourbon</surname> <given-names>C.</given-names></name> <name><surname>Robles</surname> <given-names>I.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Olesoxime accelerates myelination and promotes repair in models of demyelination</article-title>. <source>Ann. Neurol</source>. <volume>71</volume>, <fpage>213</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22593</pub-id><pub-id pub-id-type="pmid">22367994</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname> <given-names>J. L.</given-names></name> <name><surname>Langaman</surname> <given-names>C.</given-names></name> <name><surname>Morell</surname> <given-names>P.</given-names></name> <name><surname>Suzuki</surname> <given-names>K.</given-names></name> <name><surname>Matsushima</surname> <given-names>G. K.</given-names></name></person-group> (<year>2001</year>). <article-title>Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre</article-title>. <source>Neuropathol. Appl. Neurobiol</source>. <volume>27</volume>, <fpage>50</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1046/j.0305-1846.2001.00301.x</pub-id><pub-id pub-id-type="pmid">11299002</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsushima</surname> <given-names>G. K.</given-names></name> <name><surname>Morell</surname> <given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system</article-title>. <source>Brain Pathol</source>. <volume>11</volume>, <fpage>107</fpage>&#x02013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.2001.tb00385.x</pub-id><pub-id pub-id-type="pmid">11145196</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Morell</surname> <given-names>P.</given-names></name> <name><surname>Quarles</surname> <given-names>R. H.</given-names></name></person-group> (<year>1999a</year>). <article-title>&#x0201C;Characteristic composition of myelin,&#x0201D;</article-title> in <source>Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th Edn</source>, eds. G. J. Siegel, B. W. Agranoff, R. W. Albers, S. K. Fisher, and M. D. Uhler. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK28221/">https://www.ncbi.nlm.nih.gov/books/NBK28221/</ext-link> (accessed June 1, 2018).</citation>
</ref>
<ref id="B25">
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Morell</surname> <given-names>P.</given-names></name> <name><surname>Quarles</surname> <given-names>R. H.</given-names></name></person-group> (<year>1999b</year>). <article-title>&#x0201C;The myelin sheath,&#x0201D;</article-title> in <source>Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th Edn</source>, eds. G. J. Siegel, B. W. Agranoff, R. W. Albers, S. K. Fisher, and M. D. Uhler. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK28221/">https://www.ncbi.nlm.nih.gov/books/NBK28221/</ext-link> (accessed June 1, 2018).</citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plemel</surname> <given-names>J. R.</given-names></name> <name><surname>Liu</surname> <given-names>W. Q.</given-names></name> <name><surname>Yong</surname> <given-names>V. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Remyelination therapies: a new direction and challenge in multiple sclerosis</article-title>. <source>Nat. Rev. Drug Discov</source>. <volume>16</volume>, <fpage>617</fpage>&#x02013;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1038/nrd.2017.115</pub-id><pub-id pub-id-type="pmid">28685761</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Popescu</surname> <given-names>B.</given-names></name> <name><surname>Pirko</surname> <given-names>I.</given-names></name> <name><surname>Lucchinetti</surname> <given-names>C. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Pathology of multiple sclerosis: where do we stand?</article-title> <source>Contin. Lifelong Learn Neurol</source>. <volume>19</volume>, <fpage>901</fpage>&#x02013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1212/01.CON.0000433291.23091.65</pub-id><pub-id pub-id-type="pmid">23917093</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seifert</surname> <given-names>A. C.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Wilhelm</surname> <given-names>M. J.</given-names></name> <name><surname>Wehrli</surname> <given-names>S. L.</given-names></name> <name><surname>Wehrli</surname> <given-names>F. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Towards quantification of myelin by solid-state MRI of the lipid matrix protons</article-title>. <source>NeuroImage</source> <volume>163</volume>, <fpage>358</fpage>&#x02013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.09.054</pub-id><pub-id pub-id-type="pmid">28964929</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheth</surname> <given-names>V.</given-names></name> <name><surname>Shao</surname> <given-names>H.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Vandenberg</surname> <given-names>S.</given-names></name> <name><surname>Corey-Bloom</surname> <given-names>J.</given-names></name> <name><surname>Bydder</surname> <given-names>G. M.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Magnetic resonance imaging of myelin using ultrashort echo time (UTE) pulse sequences: phantom, specimen, volunteer and multiple sclerosis patient studies</article-title>. <source>NeuroImage</source> <volume>136</volume>, <fpage>37</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.05.012</pub-id><pub-id pub-id-type="pmid">27155128</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheth</surname> <given-names>V. R.</given-names></name> <name><surname>Fan</surname> <given-names>S.</given-names></name> <name><surname>He</surname> <given-names>Q.</given-names></name> <name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Annese</surname> <given-names>J.</given-names></name> <name><surname>Switzer</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Inversion recovery ultrashort echo time magnetic resonance imaging: a method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - a feasibility study</article-title>. <source>Magn. Reson. Imaging</source> <volume>38</volume>, <fpage>87</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.mri.2016.12.025</pub-id><pub-id pub-id-type="pmid">28038965</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>S. K.</given-names></name> <name><surname>Yoshino</surname> <given-names>J.</given-names></name> <name><surname>Le</surname> <given-names>T. Q.</given-names></name> <name><surname>Lin</surname> <given-names>S. J.</given-names></name> <name><surname>Sun</surname> <given-names>S. W.</given-names></name> <name><surname>Cross</surname> <given-names>A. H.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Demyelination increases radial diffusivity in corpus callosum of mouse brain</article-title>. <source>NeuroImage</source> <volume>26</volume>, <fpage>132</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2005.01.028</pub-id><pub-id pub-id-type="pmid">15862213</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soustelle</surname> <given-names>L.</given-names></name> <name><surname>Antal</surname> <given-names>M. C.</given-names></name> <name><surname>Lamy</surname> <given-names>J.</given-names></name> <name><surname>Rousseau</surname> <given-names>F.</given-names></name> <name><surname>Armspach</surname> <given-names>J. P.</given-names></name> <name><surname>de Loureiro</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Correlations of quantitative MRI metrics with myelin basic protein (MBP) staining in a murine model of demyelination</article-title>. <source>NMR Biomed</source>. <volume>2019</volume>:<fpage>e4116</fpage>. <pub-id pub-id-type="doi">10.1002/nbm.4116</pub-id><pub-id pub-id-type="pmid">31225675</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>S. W.</given-names></name> <name><surname>Liang</surname> <given-names>H. F.</given-names></name> <name><surname>Trinkaus</surname> <given-names>K.</given-names></name> <name><surname>Cross</surname> <given-names>A. H.</given-names></name> <name><surname>Armstrong</surname> <given-names>R. C.</given-names></name> <name><surname>Song</surname> <given-names>S. K.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum</article-title>. <source>Magn. Reson. Med</source>. <volume>55</volume>, <fpage>302</fpage>&#x02013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.20774</pub-id><pub-id pub-id-type="pmid">16408263</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>L. C.</given-names></name> <name><surname>Gilmore</surname> <given-names>W.</given-names></name> <name><surname>Ting</surname> <given-names>J. P. Y.</given-names></name> <name><surname>Matsushima</surname> <given-names>G. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle</article-title>. <source>J. Neurosci. Res</source>. <volume>88</volume>, <fpage>391</fpage>&#x02013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22215</pub-id><pub-id pub-id-type="pmid">19746424</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thiessen</surname> <given-names>J. D.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Buist</surname> <given-names>R.</given-names></name> <name><surname>Bigio</surname> <given-names>M. R. D.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination</article-title>. <source>NMR Biomed</source>. <volume>26</volume>, <fpage>1562</fpage>&#x02013;<lpage>1581</lpage>. <pub-id pub-id-type="doi">10.1002/nbm.2992</pub-id><pub-id pub-id-type="pmid">23943390</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varma</surname> <given-names>G.</given-names></name> <name><surname>Duhamel</surname> <given-names>G.</given-names></name> <name><surname>de Bazelaire</surname> <given-names>C.</given-names></name> <name><surname>Alsop</surname> <given-names>D. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Magnetization transfer from inhomogeneously broadened lines: a potential marker for myelin: magnetization transfer from inhomogeneously broadened lines</article-title>. <source>Magn. Reson. Med</source>. <volume>73</volume>, <fpage>614</fpage>&#x02013;<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.25174</pub-id><pub-id pub-id-type="pmid">24604578</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>N.</given-names></name> <name><surname>Zhuang</surname> <given-names>J.</given-names></name> <name><surname>Wei</surname> <given-names>H.</given-names></name> <name><surname>Dibb</surname> <given-names>R.</given-names></name> <name><surname>Qi</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Probing demyelination and remyelination of the cuprizone mouse model using multimodality MRI</article-title>. <source>J. Magn. Reson. Imaging</source>. <volume>2019</volume>, <fpage>1852</fpage>&#x02013;<lpage>1865</lpage>. <pub-id pub-id-type="doi">10.1002/jmri.26758</pub-id><pub-id pub-id-type="pmid">31012202</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>Q.</given-names></name> <name><surname>Haldar</surname> <given-names>J. P.</given-names></name> <name><surname>Yeh</surname> <given-names>F. C.</given-names></name> <name><surname>Xie</surname> <given-names>M.</given-names></name> <name><surname>Sun</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Quantification of increased cellularity during inflammatory demyelination</article-title>. <source>Brain</source> <volume>134</volume>, <fpage>3590</fpage>&#x02013;<lpage>3601</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awr307</pub-id><pub-id pub-id-type="pmid">22171354</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname> <given-names>M. J.</given-names></name> <name><surname>Ong</surname> <given-names>H. H.</given-names></name> <name><surname>Wehrli</surname> <given-names>S. L.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Tsai</surname> <given-names>P. H.</given-names></name> <name><surname>Hackney</surname> <given-names>D. B.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Direct magnetic resonance detection of myelin and prospects for quantitative imaging of myelin density</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>109</volume>, <fpage>9605</fpage>&#x02013;<lpage>9610</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1115107109</pub-id><pub-id pub-id-type="pmid">22628562</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname> <given-names>T. C.</given-names></name> <name><surname>Simmons</surname> <given-names>C.</given-names></name> <name><surname>Hurley</surname> <given-names>S. A.</given-names></name> <name><surname>Vernon</surname> <given-names>A. C.</given-names></name> <name><surname>Torres</surname> <given-names>J.</given-names></name> <name><surname>Dell&#x00027;Acqua</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Whole-brain <italic>ex-vivo</italic> quantitative MRI of the cuprizone mouse model</article-title>. <source>PeerJ</source> <volume>4</volume>:<fpage>2632</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.2632</pub-id><pub-id pub-id-type="pmid">27833805</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>M.</given-names></name> <name><surname>Tobin</surname> <given-names>J. E.</given-names></name> <name><surname>Budde</surname> <given-names>M. D.</given-names></name> <name><surname>Chen</surname> <given-names>C. I.</given-names></name> <name><surname>Trinkaus</surname> <given-names>K.</given-names></name> <name><surname>Cross</surname> <given-names>A. H.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features</article-title>. <source>J. Neuropathol. Exp. Neurol</source>. <volume>69</volume>, <fpage>704</fpage>&#x02013;<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e3181e3de90</pub-id><pub-id pub-id-type="pmid">20535036</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H. J.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Xiao</surname> <given-names>L.</given-names></name> <name><surname>Clough</surname> <given-names>R. W.</given-names></name> <name><surname>Browning</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia</article-title>. <source>Brain Res</source>. <volume>1270</volume>(Suppl.C), <fpage>121</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.03.011</pub-id><pub-id pub-id-type="pmid">19306847</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>K. M.</given-names></name> <name><surname>Psachoulia</surname> <given-names>K.</given-names></name> <name><surname>Tripathi</surname> <given-names>R. B.</given-names></name> <name><surname>Dunn</surname> <given-names>S-J.</given-names></name> <name><surname>Cossell</surname> <given-names>L.</given-names></name> <name><surname>Attwell</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling</article-title>. <source>Neuron</source> <volume>77</volume>, <fpage>873</fpage>&#x02013;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.01.006</pub-id><pub-id pub-id-type="pmid">23473318</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaaraoui</surname> <given-names>W.</given-names></name> <name><surname>Deloire</surname> <given-names>M.</given-names></name> <name><surname>Merle</surname> <given-names>M.</given-names></name> <name><surname>Girard</surname> <given-names>C.</given-names></name> <name><surname>Raffard</surname> <given-names>G.</given-names></name> <name><surname>Biran</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T</article-title>. <source>Magn. Reson. Mater. Phys. Biol. Med</source>. <volume>21</volume>, <fpage>357</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1007/s10334-008-0141-3</pub-id><pub-id pub-id-type="pmid">18779984</pub-id></citation></ref>
</ref-list>
</back>
</article>